Coastlands Capital LP insider trades
Open-market stock purchases and sales by Coastlands Capital LP, 10% Owner at Pasithea Therapeutics Corp, from SEC Form 4 filings since May 27, 2026.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +10%.
Get free alerts when Coastlands Capital LP files a new trade →